JP2024527620A5 - - Google Patents
Info
- Publication number
- JP2024527620A5 JP2024527620A5 JP2024502131A JP2024502131A JP2024527620A5 JP 2024527620 A5 JP2024527620 A5 JP 2024527620A5 JP 2024502131 A JP2024502131 A JP 2024502131A JP 2024502131 A JP2024502131 A JP 2024502131A JP 2024527620 A5 JP2024527620 A5 JP 2024527620A5
- Authority
- JP
- Japan
- Prior art keywords
- csc
- tap
- cancer
- molecule
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163203320P | 2021-07-16 | 2021-07-16 | |
| US63/203,320 | 2021-07-16 | ||
| PCT/CA2022/051068 WO2023023840A1 (en) | 2021-07-16 | 2022-07-07 | Novel tumor-specific antigens for cancer stem cells and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527620A JP2024527620A (ja) | 2024-07-25 |
| JP2024527620A5 true JP2024527620A5 (enExample) | 2025-07-11 |
Family
ID=85322248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502131A Pending JP2024527620A (ja) | 2021-07-16 | 2022-07-07 | がん幹細胞に対する新規の腫瘍特異的抗原及びそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240382590A1 (enExample) |
| EP (1) | EP4370682A4 (enExample) |
| JP (1) | JP2024527620A (enExample) |
| AU (1) | AU2022331944A1 (enExample) |
| CA (1) | CA3224907A1 (enExample) |
| WO (1) | WO2023023840A1 (enExample) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2700573C (en) * | 2006-09-26 | 2016-11-22 | Cedars-Sinai Medical Center | Cancer stem cell antigen vaccines and methods |
| EP2347769A1 (en) * | 2010-01-20 | 2011-07-27 | Glycotope GmbH | Cancer stem cell markers and uses thereof |
| KR20170095284A (ko) * | 2014-12-09 | 2017-08-22 | 훗카이도 코리츠 다이가쿠 호진 삿포르 이카 다이가쿠 | 종양 항원 펩티드 |
| MX2021002333A (es) * | 2018-08-30 | 2021-04-28 | Univ Montreal | Metodo basado en proteogenomica para identificar antigenos especificos de tumores. |
| CN118666956A (zh) * | 2019-06-25 | 2024-09-20 | 蒙特利尔大学 | 肿瘤抗原肽、肽组合、核酸、负载体、疫苗及其用途 |
| JP7711045B2 (ja) * | 2019-09-02 | 2025-07-22 | アンスティテュ・クリー | 腫瘍ネオアンチゲンペプチドを標的とする免疫療法 |
-
2022
- 2022-07-07 JP JP2024502131A patent/JP2024527620A/ja active Pending
- 2022-07-07 CA CA3224907A patent/CA3224907A1/en active Pending
- 2022-07-07 US US18/579,831 patent/US20240382590A1/en active Pending
- 2022-07-07 WO PCT/CA2022/051068 patent/WO2023023840A1/en not_active Ceased
- 2022-07-07 EP EP22859725.8A patent/EP4370682A4/en active Pending
- 2022-07-07 AU AU2022331944A patent/AU2022331944A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Barzaman et al. | Breast cancer immunotherapy: Current and novel approaches | |
| Liu et al. | mRNA cancer vaccines: construction and boosting strategies | |
| Yao et al. | Recent progress in mRNA cancer vaccines | |
| JP7005346B2 (ja) | 養子細胞免疫療法の有効性を増強させるための組成物および方法 | |
| ES2835269T5 (en) | Claudin-18.2-specific immunoreceptors and t cell epitopes | |
| CN104140974B (zh) | 编码gpc‑3嵌合抗原受体蛋白的核酸及表达gpc‑3嵌合抗原受体蛋白的t淋巴细胞 | |
| CN104087607B (zh) | 编码嵌合抗原受体蛋白的核酸及表达嵌合抗原受体蛋白的t淋巴细胞 | |
| JP2022535429A (ja) | 免疫療法のための操作されたナチュラルキラー細胞と操作されたｔ細胞の組み合わせ | |
| JP2021522820A5 (enExample) | ||
| JP6621473B2 (ja) | 癌の診断および処置のための方法および組成物 | |
| Hu et al. | Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer | |
| JP2023521219A5 (enExample) | ||
| WO2015172339A1 (zh) | 编码嵌合抗原受体蛋白的核酸及表达嵌合抗原受体蛋白的t淋巴细胞 | |
| JP6378485B2 (ja) | 抗原特異的ｔ細胞受容体およびｔ細胞エピトープ | |
| CN106146666A (zh) | 靶向cldn6的免疫效应细胞及其制备方法和应用 | |
| JP2025517138A5 (enExample) | ||
| Shariati et al. | mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy | |
| JP2023518396A5 (enExample) | ||
| JP2022538375A5 (enExample) | ||
| JP2024535853A5 (enExample) | ||
| JP2020533962A5 (enExample) | ||
| JP2023521436A5 (enExample) | ||
| Han et al. | Regulation of the translation activity of antigen-specific mRNA is responsible for antigen loss and tumor immune escape in a HER2-expressing tumor model | |
| CN110352067A (zh) | Hla限制性vgll1肽及其用途 | |
| CA3082560A1 (en) | Il-33 secreting immunoresponsive cells and uses thereof |